Cartesian Therapeutics In...

NASDAQ: RNAC · Real-Time Price · USD
11.33
-0.10 (-0.87%)
At close: Aug 15, 2025, 3:59 PM
11.80
4.15%
After-hours: Aug 15, 2025, 06:53 PM EDT

Cartesian Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-77.42M -219.71M 35.38M -25.69M
Depreciation & Amortization
1.15M 1.55M 1.29M 1.25M
Stock-Based Compensation
6.58M 22.52M 11.19M 7.72M
Other Working Capital
-10.84M 1.23M -64.71M -45.5M
Other Non-Cash Items
51.52M 158.5M 2.29M 2.13M
Deferred Income Tax
287K -19M -21.4M 2.4M
Change in Working Capital
-5.79M 4.97M -60.38M -48.19M
Operating Cash Flow
-23.67M -51.16M -31.63M -60.38M
Capital Expenditures
-9.09M -206K -1.2M -1.08M
Cash Acquisitions
n/a 6.56M n/a n/a
Purchase of Investments
n/a n/a -33.5M -32.45M
Sales Maturities Of Investments
n/a 28.25M 19.7M 16.4M
Other Investing Acitivies
351K n/a n/a n/a
Investing Cash Flow
-8.74M 34.61M -15M -17.14M
Debt Repayment
n/a -27.46M n/a n/a
Common Stock Repurchased
n/a -6.17M n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
3.99M 231K 235K 939K
Financial Cash Flow
168.43M -13.14M 39.22M 52.9M
Net Cash Flow
135.99M -29.75M -7.4M -24.63M
Free Cash Flow
-32.77M -51.37M -32.83M -61.47M